Drugs / Congrong Runtong oral liquid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05803161 | Mar 2023 → Apr 2024 | constipation disorder | Beijing Hospital of Traditional Chinese Medicine | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Congrong Runtong oral liquid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05803161 ↗ |
| Known as | CROL | “This study aimed to evaluate the efficacy and safety of Congrong Runtong Oral Liquid (CROL) in treating functional constipation of Yang-deficiency type in adults.” PMID 41759423 ↗ Feb 2026 |
| Route | Oral | “Congrong Runtong oral liquid, 2 bottles (1g herb content per bottle) per dose, three times a day” NCT05803161 ↗ |